CASM - CAS Medical Systems, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.63
+0.01 (+0.90%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close0.62
Open0.63
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.61 - 0.65
52 Week Range0.59 - 1.75
Volume30,804
Avg. Volume76,044
Market Cap17.222M
Beta-1.23
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube9 days ago

    ETFs with exposure to CAS Medical Systems, Inc. : December 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017
    Capital Cube11 days ago

    CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017

    Categories: Yahoo FinanceGet free summary analysis CAS Medical Systems, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of CAS Medical Systems, Inc. – NeuroMetrix, Inc., Utah Medical Products, Inc., Royal Philips NV Sponsored ADR, Masimo Corporation and General Electric Company (NURO-US, UTMD-US, PHG-US, MASI-US and ... Read more (Read more...)

  • Thomson Reuters StreetEvents24 days ago

    Edited Transcript of CASM earnings conference call or presentation 9-Nov-17 3:00pm GMT

    Q3 2017 CAS Medical Systems Inc Earnings Call

  • Zacks Small Cap Research26 days ago

    CASM: Operational Successes Bode Well For Restarting Sensors Sales Growth

    U.S. FORE-SIGHT sales not only returned to growth (+2% yoy and +5% qoq) in Q3, but at $3.8M, set a new record high.  But, with tissue oximetry sales falling by almost 9% yoy and roughly flat sequentially, it was far from a strong quarter as it relates to financial results.  The lack of top-line growth has recently been impacted by softness in China (as that country awaits CFDA approval of FORE-SIGHT ELITE) but remains largely tied to absence of traction in sensor sales, which account for more than 90% of tissue oximetry revenue.  As we have indicated in previous updates, the lack of sensor-related revenue growth in the face of an ever-larger monitor installed base is somewhat anomalistic, in our opinion. As it relates to the sales force, turnover has meant average tenure (and related productivity) decreased – but on the (more recent) positive side, management indicated that overall productivity has improved and sensor-related revenue growth among the more tenured reps has been relatively very strong (which could be a harbinger of maturation-correlated productivity gains among the less tenured).

  • Capital Cubelast month

    ETFs with exposure to CAS Medical Systems, Inc. : November 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Should Your Next Investment In The Healthcare Industry Be In CAS Medical Systems Inc (CASM)?
    Simply Wall St.last month

    Should Your Next Investment In The Healthcare Industry Be In CAS Medical Systems Inc (CASM)?

    CAS Medical Systems Inc (NASDAQ:CASM), a USD$20.77M small-cap, is a healthcare company operating in an industry, which faces key trends such as rising demand fuelled by an aging population andRead More...

  • How Financially Strong Is CAS Medical Systems Inc (CASM)?
    Simply Wall St.2 months ago

    How Financially Strong Is CAS Medical Systems Inc (CASM)?

    While small-cap stocks, such as CAS Medical Systems Inc (NASDAQ:CASM) with its market cap of USD $20.77M, are popular for their explosive growth, investors should also be aware of theirRead More...

  • Capital Cube2 months ago

    ETFs with exposure to CAS Medical Systems, Inc. : October 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CASM earnings conference call or presentation 9-Mar-17 3:00pm GMT

    Q4 2016 CAS Medical Systems Inc Earnings Call

  • Capital Cube2 months ago

    ETFs with exposure to CAS Medical Systems, Inc. : October 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to CAS Medical Systems, Inc. : September 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017
    Capital Cube3 months ago

    CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017

    Categories: Yahoo FinanceGet free summary analysis CAS Medical Systems, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of CAS Medical Systems, Inc. – MGC Diagnostics Corporation, Utah Medical Products, Inc., Royal Philips NV Sponsored ADR and Masimo Corporation (MGCD-US, UTMD-US, PHG-US and MASI-US) that have ... Read more (Read more...)

  • Zacks Small Cap Research4 months ago

    CASM: Clinical Superiority, Productivity Gains Bode Well For Growth Inflection

    The clinical superiority is further supported by the 75% - 85% new customer close rate when prospective clinicians perform a clinical evaluation of FORE-SIGHT.  Management noted that through the twelve months ending 6/30/17, 40% of monitor placements reflect market share gains (i.e.

  • Capital Cube5 months ago

    ETFs with exposure to CAS Medical Systems, Inc. : July 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to CAS Medical Systems, Inc. : June 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to CAS Medical Systems, Inc. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
    Capital Cube6 months ago

    CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017

    Categories: Yahoo FinanceGet free summary analysis CAS Medical Systems, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of CAS Medical Systems, Inc. – MGC Diagnostics Corporation, Utah Medical Products, Inc., NeuroMetrix, Inc., Royal Philips NV Sponsored ADR, Masimo Corporation and General Electric Company (MGCD-US, UTMD-US, ... Read more (Read more...)

  • Zacks Small Cap Research7 months ago

    CASM: Expect Salesforce Productivity, Revenue Acceleration in 2H

    Total revenue slipped by 4% yoy and by 5% sequentially to $5.22M, which was about 9% lower than our $5.73M estimate.  FORE-SIGHT sensors revenue, which accounts for approximately 77% of total revenue,  increased 8% yoy but was flat from Q4 2016.  While U.S. sensor sales had increased on a yoy basis at a double-digit rate for 27 consecutive quarters through Q4 of last year, that streak was broken with Q1 growth coming in at just 8%.  Meanwhile, international sensor revenue grew 2% yoy.

  • Capital Cube8 months ago

    ETFs with exposure to CAS Medical Systems, Inc. : April 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube9 months ago

    CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis CAS Medical Systems, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of CAS Medical Systems, Inc. – MGC Diagnostics Corporation, Utah Medical Products, Inc., Masimo Corporation, General Electric Company, Royal Philips NV Sponsored ADR and NeuroMetrix, Inc. (MGCD-US, UTMD-US, ... Read more (Read more...)

  • Zacks Small Cap Research9 months ago

    CASM: 2017 Shaping Up To Be Another Record Year

    Total revenue increased by approximately $170k, or 3%, in Q4 with 4% growth of the bread-and-butter FORE-SIGHT segment the main catalyst.  Driving FORE-SIGHT revenue was 15% growth in sensor sales – which included 16% sensors growth in the U.S. and 10% in international territories.  For the full year, total FORE-SIGHT revenue was up 17% with sensor sales increasing 22% (23% in U.S., 17% OUS).  Meanwhile, traditional monitoring sales posted growth of 1% in Q4 and 3% for the full year. Importantly, growth in the monitor installed base, fueled by market share gains at the expense of competitors as well as expansion of the overall market for cerebral oximetry, continues to drive strong sales of (high margin) FORE-SIGHT sensors.  FORE-SIGHT sensor sales remain particularly robust in the U.S. with Q4 ’16 marking the 27th straight quarter of double-digit U.S. sensor sales growth and we think this trend will continue.

  • Zacks Small Cap Research11 months ago

    CASM: Q4 Revenue Growth of 14%, Further Acceleration in 2H 2017

    CAS Medical (CASM) preannounced Q4 and full year 2016 revenue and provided general guidance for 2017.  While the Q4 numbers were slightly below what we had been looking for, the revision implies FY2016 revenue growth will still be a relatively beefy 14% and driven by 17% growth of the company’s flagship FORE-SIGHT tissue oximetry segment.  The revision also has no impact on our forecasted EPS or calculated per-share price target. Much of the difference relative to our prior revenue estimate relates to a greater number of monitor returns in Q4 (37 A vs. 21 E) – but despite this, CASM was still able to ship a record number of monitors to U.S. customers.  We remind investors that a certain number of monitors are regularly returned each quarter as lower utilization sites are weeded out – Q4 was somewhat of an anomaly due to the loss of a top-50 account which resulted in greater than usual returns and what we expect to be a short-term hiccup in net monitor placement growth.  While as of the Q3 call (mid-November) management was still guiding to hit their goal of 400 monitor placements in 2016, the Q4 preannouncement implies total placements will come in about 5% shy of this, or 380.

  • How Cogentix Medical Inc (CGNT) Ranks Amongst Its Peers
    Insider Monkeylast year

    How Cogentix Medical Inc (CGNT) Ranks Amongst Its Peers

    The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines. Of course, most hedge funds and other asset managers have been underperforming main stock market indices since the middle of 2015. Interestingly though, smaller-cap stocks registered their best performance relative to the large-capitalization […]

  • Capital Cubelast year

    ETFs with exposure to CAS Medical Systems, Inc. : December 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)